Today is World Asthma Day 2019. EIT Digital has launched its new digital prescription service to improve adherence to asthma therapy.
Amiko, Reply and the University of Twente have partnered in the ACT4Y (Asthma Control For You) innovation activity, part of EIT Digital’s Digital Wellbeing focus area portfolio. Together they have created the world’s first digital prescription intervention service, to improve adherence to asthma therapy.
World Asthma Day 2019
Asthma is a chronic disease characterized by recurrent attacks of breathlessness and wheezing, which vary in severity and frequency from person to person.
Facts about asthma:
- It affects over 300 million people worldwide;
- The number of people with asthma is expected to increase to 400 million by 2025;
- Each year asthma hospitalisations and emergency department visits cost over $50B in the US and €70B in Europe;
- Many asthma-related exacerbations are preventable with proper asthma therapy.
How the digital prescription service works
Patients are given devices to attach to the inhalers they use to track medication use, as well as other parameters to detect inhaler technique and the quality of the inhalations.
Pharmacists are given a web application which receives the data generated by the sensors. It displays metrics for an improved understanding of inhaler use and misuse. It offers an overview of asthma therapy treatment compliance over time.
This information is used to provide digital medication use reviews to patients. According to EIT Digital, this improves:
- Medication adherence;
- Inhaler technique;
- Asthma control and
- Prevention of unnecessary exacerbations of the disease, often leading to ER visits and costly hospitalisations.
EIT Digital is a leading European digital innovation and entrepreneurial education organisation driving Europe’s digital transformation, in the following ways:
- Commercialising digital innovations;
- Educating entrepreneurial talent; and
- Running a pan-European network of over 130 top European corporations, SMEs, start-ups, universities and research institutes.
There are co-Location Centres in Berlin, Eindhoven, Helsinki, London, Paris, Stockholm, Trento, as well as in Budapest and Madrid.
Amiko’s CCO and ACT4Y’s activity leader Martijn Grinovero said, commented: “We’ve been proud members of EIT Digital since 2017. Over the years, we’ve collaborated closely with the Digital Wellbeing team to deliver breakthrough patient experiences. ACT4Y is the realisation of EIT Digital’s ambition to accelerate the market uptake of high impact, evidence-based digital health technologies.”